Author: openjargon

  • Why are Sayona Mining shares outperforming other ASX lithium stocks today?

    Sayona Mining Ltd (ASX: SYA) shares are having a relatively positive session.

    At the time of writing, the lithium miner’s shares are flat at 3.5 cents.

    This compares favourably to many of other ASX lithium stocks today.

    For example, Pilbara Minerals Ltd (ASX: PLS) shares are down 1.5%, Core Lithium Ltd (ASX: CXO) shares have tumbled 3%, and Liontown Resources Ltd (ASX: LTR) shares are almost 4% lower.

    Why are Sayona Mining shares outperforming?

    It appears that the release of an announcement this morning has given investor sentiment a boost and kept the lithium miner’s shares above water.

    According to the release, the results from 36 new drillholes totalling 8,803 metres at its 75% owned North American Lithium (NAL) operation in Quebec, Canada, are demonstrating “the high-grade nature of this strategic asset.”

    The company notes that all the drilling results from the 2023 exploration program are now complete, validated, and released. Furthermore, the first results from the 2024 exploration drilling program, which is currently underway, are now being reported.

    Management believes the 2023 drill program has been successful in demonstrating the potential to increase the mineral resource base at NAL. It highlights that it was designed to test extensions to mineralisation and provide in-fill data for the upgrade of mineral resource categories.

    The latest drilling results include the identification of high-grade lithium mineralisation outside the mineral resource estimate (MRE) pit shells. This is particularly the case in the North-West and South-East extensions. It feels this supports the potential conversion of some of the inferred resources to indicated category within the MRE pit shells.

    ‘Superb quality’

    Sayona Mining’s interim CEO, James Brown, appeared to be very pleased with the strong drilling results. He commented:

    We are delighted to have another strong set of drilling results from North American Lithium which continue to highlight the superb quality of this mine. The results reported today have shown that mineralisation continues outside of the existing MRE pit shells so the next key step will be to complete a recalculation of the MRE to include recent drilling. Additionally, we will also complete a further 30,000 metres of drilling throughout 2024 to better understand the full potential of the NAL mineralisation.

    The news hasn’t been enough to prop up the shares of Piedmont Lithium Inc (ASX: PLL), which owns the remaining 25% interest in the NAL project. Its shares are down 3% to 15 cents at the time of writing.

    The shares of both Sayona Mining and Piedmont Lithium remain down over 80% on a 12-month basis.

    The post Why are Sayona Mining shares outperforming other ASX lithium stocks today? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Willie Mays, San Francisco Giants legend, dead at 93

    Circa 1958, American baseball player Willie Mays #24 of the San Francisco Giants poses in uniform in a stadium.
    Baseball player Willie Mays has died.

    • Willie Mays, baseball Hall of Famer and San Francisco Giants legend, is dead at 93.
    • He retired in 1973 and was inducted into the Baseball Hall of Fame in 1979.
    • "Today we have lost a true legend," Giants Chairman Greg Johnson said in a statement.

    Willie Mays, the Hall of Famer with a career that spanned 22 seasons, has died at age 93, the San Francisco Giants announced in a post on X on Tuesday.

    "Today we have lost a true legend," Giants Chairman Greg Johnson said in a statement. "In the pantheon of baseball greats, Willie Mays' combination of tremendous talent, keen intellect, showmanship, and boundless joy set him apart. A 24-time All-Star, the Say Hey Kid is the ultimate Forever Giant. He had a profound influence not only on the game of baseball, but on the fabric of America. He was an inspiration and a hero who will be forever remembered and deeply missed."

    Mays was named the league's Most Valuable Player twice and won the World Series with the Giants in 1954.

    He retired in 1973 with 24 All-Star awards and was inducted into the Baseball Hall of Fame in 1979.

    Read the original article on Business Insider
  • Guess which high-flying ASX All Ords stock was just halted ahead of a key FDA decision

    woman sitting at desk holding hand up in stop motion

    The All Ordinaries Index (ASX: XAO) is up 0.1% in morning trade today, but this ASX All Ords stock isn’t going anywhere just yet.

    Shares in the clinical dermatology company closed at 34 cents apiece yesterday, which sees the stock up almost 18% in five days.

    Today shares in the ASX All Ords stock entered a trading halt pending a key approval announcement from the United States Food & Drug Administration (FDA). Shares are expected to resume trading this Friday.

    Any guesses?

    If you said Botanix Pharmaceuticals Ltd (ASX: BOT), go to the head of the virtual class.

    Here’s what’s happening.

    What’s happening with the ASX All Ords stock?

    Last Wednesday, 12 June, Botanix announced that it had submitted the last label materials to the FDA for its prescription product Sofdra. Sofdra is developed to treat excessive underarm sweating. Also known as primary axillary hyperhidrosis, for our medically inclined readers.

    That announcement saw the ASX All Ords stock charge higher over the next three trading days.

    Investor enthusiasm looks to have been piqued by the company noting that its labelling discussions present the final step before the “anticipated FDA approval of Sofdra”. Botanix said its been in discussions with the FDA on product carton design and the wording of information to be provided to patients and physicians about Sofdra.

    Commenting on the anticipated approval that sees the ASX All Ords stock in a trading halt today, Botanix CEO Howie McKibbon said:

    Our team has been highly focused on completing these last label components, well in advance of approval.

    Our label and packaging materials are an important part of the materials that we will use to communicate important safety and efficacy information upon approval of Sofdra.

    The company said that FDA approval for Sofdra remains on target for this Friday, 21 June. Upon approval, it said that Sofdra will be the first new chemical entity approved for excessive underarm sweating.

    Atop of Sofdra, the ASX All Ords stock has a range of other products in late-stage clinical development to potentially treat a variety of dermatology conditions.

    Botanix share price snapshot

    If you look back to the chart up top, you’ll see just how strong the Botanix share price has performed over the past months.

    In 2024 alone, the ASX All Ords share has gained 76%.

    Investors who bought shares 12 months ago will be sitting on gains of 205%.

    And savvy investors who bought shares at the very end of 2022 (30 December) will have seen those shares rocket by 570%.

    The post Guess which high-flying ASX All Ords stock was just halted ahead of a key FDA decision appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • QBE shares drop on half year update and strategic review

    QBE Insurance Group Ltd (ASX: QBE) shares are under pressure on Wednesday morning.

    At the time of writing, the insurance giant’s shares are down 1.5% to $18.08.

    Why are QBE shares falling?

    Investors have been selling the company’s shares this morning after it released an update on its North American strategic review and its expectations for the first half of FY 2024.

    In respect to the former, the insurer has revealed that it plans to commence an orderly closure of its North America middle-market segment.

    According to the release, the segment represented gross written premium of ~US$500 million in FY 2023 and has experienced performance challenges over several years.

    Management believes that the closure of middle-market will serve to refocus North America’s strategy on those businesses, which hold more meaningful market position, relevance and scale.

    The good news is that the closure will have no incremental impact on appetite or strategy for North America’s three core businesses, Specialty, Crop and Commercial.

    QBE intends to begin non-renewing middle-market policies in accordance with applicable state regulations, with gross written premium expected to begin reducing in FY 2024, before falling more substantially in FY 2025.

    A restructuring charge of ~US$100 million before tax will be recorded in the FY 2024 result to account for costs associated with the business closure. Positively, the closure is expected to have limited impact on QBE’s FY 2024 group combined operating ratio.

    Half year update

    With QBE rapidly approaching the end of its first half, it has taken this opportunity to update the market on its expectations for the six months.

    The release reveals that first half gross written premium is expected to be ~US$13.1 billion. This represents constant currency growth of ~3% on the prior corresponding period, with net insurance revenue expected to be ~US$8.4 billion.

    Group catastrophe costs in the five months to May 2024 are estimated at ~US$500 million. This compares to its first half catastrophe budget of US$609 million. Recent events have included US convective storms, the Dubai floods, and an initial estimate of US$175 million to US$225 million to account for QBE’s net exposure to the ongoing civil unrest in New Caledonia.

    QBE’s investment performance has been solid. It notes that total investment income in the five months to May 2024 was US$643 million. This improved from US$406 million during the first quarter. The result includes a favourable credit spread impact of US$76 million and a risk asset result of US$104 million. As of May, the net impact from asset liability management activities remained neutral.

    In light of the above and based on its preliminary view of its half year result, QBE continues to expect FY 2024 group constant currency gross written premium growth in the mid-single digits, and a FY 2024 group combined operating ratio of ~93.5%.

    QBE shares remain up 18% over the last 12 months.

    The post QBE shares drop on half year update and strategic review appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • What you may not know about the Betashares Nasdaq 100 (NDQ) ETF

    a person with an uncomfortable, questioning expression and arms outstretched as if asking why?

    The exchange-traded fund (ETF) Betashares Nasdaq 100 ETF (ASX: NDQ) provides a way for Australian investors to gain exposure to the biggest companies listed on the US-based NASDAQ stock exchange.

    The ETF seeks to track the performance of the largest 100 stocks by market capitalisation. This group is collectively the NASDAQ-100 Index (NASDAQ: NDX).

    When you think of the NASDAQ, the first thing that may come to mind is mega US tech stocks.

    That’s understandable, given that the NASDAQ is home to the Magnificent Seven — six of which are, indeed, mega US tech stocks.

    Just to remind you, the Magnificent Seven stocks are Meta Platforms Inc (NASDAQ: META), Amazon.com, Inc. (NASDAQ: AMZN), Apple Inc (NASDAQ: AAPL), Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG), Nvidia Corp (NASDAQ: NVDA), Microsoft Corp (NASDAQ: MSFT), and Tesla Inc (NASDAQ: TSLA).

    Tesla is the outlier among the group as it is in the consumer cyclical market sector.

    And it’s not the only non-tech business in the NASDAQ 100, either.

    The first thing you may not know

    While the NASDAQ 100 (and thus, the Betashares Nasdaq 100 ETF) is certainly ‘overweight’ in tech stocks, there are also many stocks from other sectors.

    Here is the latest Betashares Nasdaq 100 ETF sector allocation, as published on betashares.com.au.

    As you can see, only half the NDQ ETF’s allocation is tech stocks.

    At the recent ASX Investor Day held in Sydney, Betashares investment strategist Tom Wickenden pointed out that the Betashares Nasdaq 100 ETF was a particularly complementary holding for ASX 200 investors.

    One reason is their opposite sector weightings.

    The S&P/ASX 200 Index (ASX: XJO) is dominated by banks and major miners, while the NDQ ETF is dominated by tech stocks.

    The ASX 200 comprises 30.6% financial shares, 22.7% materials shares, and only 3.2% tech stocks. In contrast, the NDQ ETF has only 1.5% materials shares, 0.5% financial shares, and 50.5% tech stocks.

    Furthermore, the NDQ ETF complements ASX 200 shares because it offers geographical diversification beyond Australia — and not just to the US economy, either.

    This brings us to the second thing you may not know about the Betashares Nasdaq 100 ETF.

    Only 50% of earnings come from the US

    Although the NASDAQ is a US-based stock exchange and comprises many big-name US-based companies, NASDAQ 100 businesses tend to be global in nature with a globally diverse customer base.

    This means they generate revenue in many different countries and are exposed to many different economies.

    So, while you may initially associate the NASDAQ with the United States, it’s worth knowing that only 50.3% of revenue generated by the NASDAQ 100 comes from the US.

    The rest comes from various other countries, with a revenue split very similar to the MSCI World Index.

    Take a look.

    Source: Betashares.com.au

    This is notable because investors tend to look to MSCI indexes to attain worldwide diversification for their portfolios.

    The MSCI World Index comprises 1,464 stocks across 23 developed countries. According to msci.com, the index “covers approximately 85% of the free float-adjusted market capitalization in each country”.

    So, it’s interesting to note that the Betashares Nasdaq 100 ETF can offer virtually the same geographical earnings diversification, but your investment is more concentrated with just 100 stocks instead of 1,464.

    Is that a positive or negative? You decide. We’re just letting you know.

    An ‘investment in innovation’

    Wickenden points out that the NASDAQ 100 “is the home of innovation globally” and thereby represents an investment in not just technology but also innovation, which encapsulates so much more than IT.

    And ’tis the era, right?

    Did someone say electric vehicles? Or green steel?

    Wickenden says that of the nine listed companies to ever touch the trillion-dollar mark in market capitalisation, seven have achieved their success through major innovation.

    Of course, those seven stocks are the Magnificent Seven. (Fun fact: The other two stocks that reached US$1 trillion were PetroChina and Saudi Aramco.)

    He also says that innovation requires a serious commitment to research and development (R&D), and the NASDAQ 100 (and thus the Betashares Nasdaq 100 ETF) gives investors exposure to such companies.

    Wickenden said:

    If we look under the hood of the NASDAQ 100, what we find is it’s home to some of the most innovative companies in the world and also some of the biggest R&D spenders in the world.

    We can see … over the past 10 years huge growth of research and development spending has coincided with huge growth of revenue and ultimately earnings growth for that index compared to other companies globally and especially compared to the Australian market.

    Wickenden used Microsoft as a case study.

    He said a huge investment in cloud computing many years ago resulted in Microsoft’s cloud computing division alone delivering more revenue than Australia’s Big Four banks combined last year.

    You can check out the NDQ ETF’s entire portfolio and weightings here.

    The Magnificent Seven’s weightings in the NDQ ETF at the time of writing are Apple 8.6%, Microsoft 8.5%, Nividia 8.4%, Alphabet 5.3%, Amazon 4.9%, Meta 4.5%, and Tesla 2.3%.

    A short price history on Betashares Nasdaq 100 ETF

    The Betashares Nasdaq 100 ETF closed Tuesday’s session at $45.60 per unit, up 0.75% for the day.

    The NDQ ETF has risen 22% in the year to date and 34% over the past 12 months.

    The post What you may not know about the Betashares Nasdaq 100 (NDQ) ETF appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    More reading

    Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Motley Fool contributor Bronwyn Allen has positions in BetaShares Global Sustainability Leaders ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon.com, Apple, BetaShares Nasdaq 100 ETF, Meta Platforms, Microsoft, Nvidia, and Tesla. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended Alphabet, Amazon.com, Apple, Meta Platforms, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Near its 52-week low, this ASX growth stock could be the bargain of the year!

    Man waiting for his flight and looking at his phone.

    The Corporate Travel Management Ltd (ASX: CTD) share price has fallen to a 52-week low, as we can see on the chart below. It’s also down 32% since the start of 2024.

    The ASX travel share has lost investor confidence after the FY24 first-half result wasn’t as strong as some investors were hoping.

    Corporate Travel Management said macro issues beyond the control of the business impacted performance in the second quarter of 2024. That included negative travel sentiment relating to conflict in the Middle East, American client calendar-year travel budgets being fully utilised by the end of the FY24 first quarter due to “unsustainably high ticket prices” and a slower Chinese outbound recovery.

    These issues affected FY24’s second-quarter earnings before interest, tax, depreciation, and amortisation (EBITDA) by approximately $15 million.

    It also said the UK bridging contract is “materially underperforming” compared to the client’s initial expectations because of immigration challenges and timing delays. This is expected to have a $25 million impact to the full-year result.

    But the ASX growth stock could have a very promising outlook for the rest of the decade.

    Why the Corporate Travel Management share price could be undervalued

    For starters, the business said the macro issues in the second quarter “appear to have dissipated, with the group experiencing a strong rebound in January 2024.” These issues are “unlikely to impact 2H24”.

    The company has a five-year growth strategy to double its FY24 profit organically by FY29, which would represent a compound annual growth rate (CAGR) of 15%, with any acquisitions adding to the growth.

    Firstly, the company is aiming to grow its revenue by at least 10% per annum over five years by winning new clients. The new win target starts at $1 billion per annum and will increase to $1.6 billion per annum by FY29.

    Second, the ASX growth stock wants to keep its client retention rate of 97% each year. The company is expecting client activity will grow by 3% per annum, offsetting any client losses.

    Third, it’s hoping that its key projects will achieve revenue gains and savings over time, with a target of costs to only grow by 5% per annum. Revenue per full-time employee improvement will be a key performance measure of progress. Future projects are aimed at both market share growth and automation.

    Fourth, Corporate Travel wants 50% of every new dollar of revenue to fall to the EBITDA profit line as it wins new clients, retains existing clients and implements the above-mentioned cost projects. This can translate into the EBITDA growing at a CAGR of 15% over five years.

    Finally, any acquisitions are in addition to the above plans. Most acquisition targets are “highly leveraged with debt to survive COVID”. The ASX travel share is “actively pursuing” these opportunities, which will add “further growth, shareholder value and economies of scale.”

    If the company executes its plans well and doubles its profit in the next five years, I think it could be a great market-beater, as long as technology and AI don’t negatively disrupt the travel industry.

    ASX growth stock valuation

    According to the estimates on Commsec, the ASX growth stock is valued at 16x FY24’s estimated earnings and just 12x FY26’s estimated earnings.

    The post Near its 52-week low, this ASX growth stock could be the bargain of the year! appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Corporate Travel Management. The Motley Fool Australia has positions in and has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Jeff Bezos weighs in on the chaos gripping his newspaper

    Jeff Bezos in tuxedo
    Jeff Bezos said an internal memo that he was committed to maintaining The Washington Post's journalistic standards.

    • Jeff Bezos told Washington Post staffers Tuesday that their journalistic standards will not change.
    • The memo came as the Post's publisher and incoming editor face criticism over past reporting.
    • Bezos said he was committed to maintaining the Post's "quality, ethics, and standards."

    Jeff Bezos, the owner of The Washington Post, tried to assure staffers on Tuesday that the journalistic standards at the newspaper will not change as controversies mount over its new publisher and incoming editor.

    "The journalistic standards and ethics at the Post will not change," Bezos wrote in the email, which was obtained by CNN. He also copied Will Lewis, publisher and CEO of the Post, on the email.

    "To be sure, it can't be business as usual at The Post. The world is evolving rapidly, and we do need to change as a business," Bezos said, adding, "With your support, we'll do that and lead this great institution into the future. But, as the newsroom leaders who've been shaping and guiding our coverage, you also know our standards at The Post have always been very high. That can't change — and it won't."

    He continued, "You have my full commitment on maintaining the quality, ethics, and standards we all believe in."

    The billionaire owner's email comes as Lewis faces criticism related to the phone-hacking scandal that rocked the UK starting in 2011 when it was revealed that reporters at a British tabloid had hacked the phone records of celebrities and private citizens and that some had paid sources for information. Lewis was brought into News Corp. to deal with the fallout.

    The New York Times on Saturday reported that Lewis himself had assigned stories based on "fraudulently obtained" phone and company records in the early 2000s when he was a business editor at The Sunday Times.

    The Post published a story on Sunday that said a self-described "thief" who stole records for stories was connected to Lewis and Robert Winnett, the Post's incoming editor.

    Bezos did not immediately respond to a request for comment sent by BI. The Post did not provide comment when reached by BI. Previously, The Post told The Times, "William is very clear about the lines that should not be crossed, and his track record attests to that."

    Winnett was tapped to take over the Post newsroom this fall after Executive Editor Sally Buzbee abruptly stepped down this month, with former Wall Street Journal Editor in Chief Matt Murray stepping into the role until after the election.

    The Times, citing unnamed sources, reported earlier this month that Buzbee and Lewis had clashed over whether to cover a legal development in a lawsuit related to the phone-hacking scandal.

    Beyond controversies involving its leadership, the Post has also been struggling financially.

    Bezos bought the Post for around $250 million in 2013, but the Times reported the newspaper had $100 million in losses in 2023. The Post also cut 240 jobs at the end of last year.

    Read the original article on Business Insider
  • Microplastics found in penis muscle for the first time. It could be linked to erectile dysfunction.

    Boxers made out of a photo of microplastics
    • A small study of men with erectile dysfunction found microplastics hiding in most of their penises.
    • An older man with a traditional lifestyle was the only one who didn't have microplastic in his penis.
    • Scientists don't totally understand how microplastics affect reproductive health, but they're worried.

    When scientists first started murmuring about a striking connection between more microplastics and more heart attacks, Dr. Ranjith Ramasamy's mind immediately traveled further south, to another blood-pumping organ, one that he knows very well.

    "Penis being such a vascular organ, similar to the heart, we said, 'Hey, could this also be present in the penis?'"

    Ramasamy, a reproductive urology specialist who has conducted penile implant surgeries in Miami for many years, wondered how the microplastics that we inadvertently inhale from everyday items including food, water bottles, and household dust, might impact fertility and verility in men.

    What he's found, while still preliminary, is that microplastics are present in some penises experiencing erectile dysfunction (ED).

    Microplastics were found in 80% of penises with ED in this small study

    plastic bottles
    Most of the microplastic found in penises was the kind that's used to manufacture plastic bottles.

    Ramasamy's first-of-its-kind study, just released in the International Journal of Impotence Research, was a small, pilot sample of six men, all with ED, each one undergoing surgery to insert a penile implant.

    While the study is still preliminary, it's part of a growing body of research that finds microplastics are present everywhere in the human body that researchers have looked so far.

    It's also one of the first studies to study a connection between impotence and more plastic use. Other studies have already suggested there may be some link between our plastic modern existence and lower-quality sperm. Ramasamy wanted to know whether microplastics might physically impact penis muscle function.

    At the start of each surgery, Ramasamy carefully extracted some tissue from deep inside the shaft of the penis — an area that's responsible for making and sustaining erections. He and his team worked to ensure there was no plastic contamination in the surgery rooms by using non-plastic surgical instruments and collecting the tissue in glass containers. They then whisked the tissue off to two separate labs for analysis.

    Scientists found microplastics present in five of the six penises they sampled. The most abundant plastic in the penises was polyethylene terephthalate, or PET, a common plastic used in food packaging including plastic bottles and takeout containers. They also found polypropylene, which is used to make plastic bottle caps.

    We are gobbling up more plastics than ever, and learning more about the effects

    takeout food
    Most takeout containers are lined with plastic coating (yes, even the cardboard ones.)

    We don't know how much plastic might be hiding out in the penises of men without ED and can't take much away from such a small initial study.

    Still, this research goes hand in hand with what other microplastics experts are discovering.

    We are consuming more plastic than ever before. In several recent microplastic studies, younger men have had more microplastic in them than older men.

    The one man in this study who didn't have any detectable microplastics in his penis "leads a very traditional, Cuban guy elderly lifestyle," Ramasamy said. "He said he doesn't use a lot of plastics."

    He's not getting a lot of the takeout that often comes in plastic-lined containers, and he's not drinking from plastic-lined coffee cups or plastic water bottles very often. In other words, without trying, he's doing most of the things that microplastic researchers recommend to people hoping to reduce their risk of any potential microplastic-related health issues: avoiding drinking and eating from plastic, and never microwaving plastic containers.

    This finding has given Ramasamy pause. He has become much more wary of drinking from plastic water bottles since completing this study, and he tries to always put his food on a real plate now before he re-heats it, instead of microwaving plastic tubs. He knows it's still unclear what contribution microplastics might be making to infertility and low sperm quality, but he's got a hunch there's probably some contribution, on some level.

    "As convenient as society has become, I think we're facing some of these harms," he said. "I don't think our parents were exposed to as much: They were not drinking water out of plastic bottles — they were certainly not doing as much takeout."

    Could microplastics be interfering with important penis muscles?

    penis enlargement
    Microplastics could impact smooth muscle function, Ramasamy suggested.

    Microplastics have traveled to almost every corner of the body that scientists have looked at so far, including lungs, livers, blood vessels, penises, and brains, as well as fluids including semen, blood, and placentas. Just last month, researchers at the University of New Mexico found microplastics in testicles, cementing the idea that microplastics can penetrate the body's protective blood-testes barrier. What these tiny bits of plastic are doing to our bodies remains an open question.

    Richard Pilsner, a men's reproductive health expert at Wayne State University who studies the chemicals in plastics, says "we have a lot to learn in terms of where it's accumulating and what processes it may be affecting." Recent work he's done suggested that men with higher levels of plasticizers and plastic chemicals in their bodies see their sperm age faster, in a similar way to cigarette smokers.

    "It kind of is all pointing in the same direction — that these environmental factors are influencing sperm fitness," he said.

    While the impact of microplastics on erections is unclear, that's nothing new in this field. Erections are still a very poorly understood, multifactorial phenomenon, involving nerves, hormones, muscles, and interest.

    Ramasamy is confident that this is seriously worth investigating, especially given the recent link between more microplastics in blood vessels pumping oxygen to the brain, and more heart attacks and strokes. Couldn't it also be the case that microplastics are connected to erection issues, in a similar, physical way?

    "You could have good blood supply, but if you don't have the actual muscle to do the heavy lifting, how are you going to make it work?" he said.

    Read the original article on Business Insider
  • 2 ASX ETFs I would happily buy today for my retirement

    An elderly retiree holds her wine glass up while dancing at a party feeling happy about her ASX shares investments especially Brickworks for its dividends

    Legendary investor Warren Buffett said a low-cost index fund is the most sensible equity investment for the great majority of investors.

    Many investors enthusiastically embrace exchange-traded funds (ETFs) as an excellent choice for building a diversified and resilient retirement portfolio, and with good reason.

    Buffett advocates cost-effective investing, highlighting ETFs for their low expense ratios and investors’ ability to keep more money invested. ETFs offer flexibility similar to stocks, allowing for portfolio adjustments in tune with retirement goals and market dynamics.

    With that in mind, here are my two ASX ETF picks for retirement.

    Vanguard Australian Shares Index ETF (ASX: VAS)

    Let’s kick off with the Vanguard Australian Shares Index ETF. This ETF is a prime example of Buffett’s invaluable advice in action. It offers extensive exposure to the Australian equity market, comprising the top 300 companies listed on the ASX.

    This ETF is designed to track the return of the S&P/ASX 300 Index (ASX: XKO), which includes Australia’s major players such as BHP Group Ltd (ASX: BHP), Commonwealth Bank of Australia (ASX: CBA), and CSL Ltd (ASX: CSL).

    Another important consideration is its fees. The VAS ETF is popular due to its low management fee of just 0.1% per annum, making it an even more attractive investment option.

    This ETF is ideal for those seeking regular income, paying quarterly dividends. Over the past 12 months to April 2024, it provided total dividends of $3.741, yielding 3.9% at the current share price, with around 80% franking credits.

    Over the last 10 years, VAS has generated a total return of 7.7% per year, comprising 3.2% capital growth and 4.5% income return.

    The VAS ETF unit price was trading at $96.73 after closing on Tuesday.

    Betashares Nasdaq 100 ETF (ASX: NDQ)

    Now, for those eager to broaden their investment horizons, Betashares Nasdaq 100 ETF stands out as an exceptional choice.

    With Australia accounting for just 2% of the global financial market, it’s crucial to diversify beyond domestic equities when planning for retirement.

    NDQ offers an affordable entry point into the United States market, focusing on tech-heavy and growth-oriented stocks within the NASDAQ-100 Index. Big names include Nvidia, Amazon, Apple and Alphabet. This not only serves as a hedge against domestic market volatility but also adds substantial value by capturing growth opportunities in the global market.

    The ETF’s management fee is 0.48% per annum, which is higher than VAS but reflects its specialised exposure to high-growth tech stocks.

    Since its inception in May 2015, the ETF has generated an average annual return of 19.48%, which is phenomenal.

    The NDQ ETF unit price closed at $45.60 on Tuesday.

    The post 2 ASX ETFs I would happily buy today for my retirement appeared first on The Motley Fool Australia.

    Maximise Your Super before June 30: Uncover 5 Strategies Most Aussies Overlook!

    With the end of the financial year almost upon us, there are some strategies that you may be able to take advantage of right now to save some tax and boost your savings…

    Download our latest free report discover 5 super strategies that most Aussies miss today!

    Download Free Report
    *Returns 28 May 2024

    More reading

    Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor Kate Lee has positions in Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Apple, BetaShares Nasdaq 100 ETF, CSL, and Nvidia. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended Alphabet, Amazon, Apple, CSL, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Could Apple’s latest move boost Zip shares?

    Zip Co Ltd (ASX: ZIP) shares pushed higher on Tuesday.

    The buy now pay later (BNPL) provider’s shares rose 2.5% to $1.44.

    This appears to have been driven by news from across the Pacific.

    What gave Zip shares a boost?

    There were fears last year that tech behemoth Apple Inc (NASDAQ: AAPL) was going to steal market share away from Zip in the United States with the launch of Apple Pay Later.

    However, less than a year after launching its BNPL offering, the iPhone maker has decided to discontinue the service. This means one less player for Zip to compete with in the lucrative US market.

    According to a press release, Apple decided to scrap its Apple Pay Later service after announcing that third-party services would be integrated into its upcoming iOS 18 software. It commented:

    Starting later this year, users across the globe will be able to access installment loans offered through credit and debit cards, as well as lenders, when checking out with Apple Pay. With the introduction of this new global installment loan offering, we will no longer offer Apple Pay Later in the US.

    In addition, it is worth noting that the new service will be made available globally (not just in the US) through the company’s Apple Pay platform with the launch of iOS 18. It adds:

    Our focus continues to be on providing our users with access to easy, secure and private payment options with Apple Pay, and this solution will enable us to bring flexible payments to more users, in more places across the globe, in collaboration with Apple Pay enabled banks and lenders.

    What is unclear, though, is whether Zip will be one of the third-party providers that will be integrated into the software. If it is, it could be a big boost to Zip’s growth in the coming years.

    Conversely, if one of its rivals has the honour of being integrated, it could potentially cause some headwinds for Zip.

    Should you invest?

    With Zip shares up 205% over the last 12 months, analysts believe that potential upside is now becoming somewhat limited.

    For example, both UBS and Ord Minnett currently have buy ratings on the BNPL provider’s shares. However, with price targets of $1.55, this suggests that Zip’s shares could rise a modest 7.6% over the next 12 months.

    This could make it worth waiting for a better entry point and further clarification on Apple Pay’s integrations.

    The post Could Apple’s latest move boost Zip shares? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    See The 5 Stocks
    *Returns as of 5 May 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Apple and Zip Co. The Motley Fool Australia has recommended Apple. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.